AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

H Huynh, HN Koong, D Poon, SP Choo, HC Toh… - Journal of …, 2010 - Elsevier
BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) is a particularly vascularized solid
tumor where the Raf/MEK/ERK pathway is activated; suggesting that inhibition of this …
被引用次数：120 相关文章

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

H Huynh, HN Koong, D Poon, SP Choo… - Journal of …, 2010 - pubmed.ncbi.nlm.nih.gov
Background & aims Hepatocellular carcinoma (HCC) is a particularly vascularized solid
tumor where the Raf/MEK/ERK pathway is activated; suggesting that inhibition of this …

[引用][C] AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

H HUYNH, NGO VAN CHANH, BC GOH… - Journal of …, 2010 - pascal-francis.inist.fr
Author HUYNH, Hung 1; VAN CHANH NGO 1; BOON CHER GOH 6; SMITH, Paul D 7;
KHEE CHEE SOO 1; HENG NUNG KOONG 2; POON, Donald 3; SU PIN CHOO 3; HAN …

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).

H Huynh, VC Ngo, HN Koong, D Poon… - Journal of …, 2009 - europepmc.org
Methods We treated patient-derived HCC xenografts with (i) sorafenib,(ii) AZD6244 (ARRY-
142886), and (iii) sorafenib plus AZD6244. Western blotting was employed to determine …

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

H Huynh, HN Koong, D Poon, SP Choo… - Journal of …, 2010 - journal-of-hepatology.eu
Background & Aims Hepatocellular carcinoma (HCC) is a particularly vascularized solid
tumor where the Raf/MEK/ERK pathway is activated; suggesting that inhibition of this …
[PDF] academia.edu

[PDF][PDF] AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

H Huynh, HNK Van Chanh Ngo, D Poon… - Journal of …, 2010 - academia.edu
Background & Aims: Hepatocellular carcinoma (HCC) is a particularly vascularized solid
tumor where the Raf/MEK/ERK pathway is activated; suggesting that inhibition of this …

[引用][C] AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

H HUYNH - J Hepatol, 2010 - cir.nii.ac.jp
AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of
human hepatocellular carcinoma (HCC) | CiNii Research CiNii 国立情報学研究所 学術情報 …

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

H Huynh, VC Ngo, KC Soo, HN Koong, D Poon… - 2010 - scholarbank.nus.edu.sg
Background & Aims: Hepatocellular carcinoma (HCC) is a particularly vascularized solid
tumor where the Raf/MEK/ERK pathway is activated; suggesting that inhibition of this …

AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

H Huynh, HN Koong, D Poon, SP Choo, HC Toh… - Journal of …, 2010 - infona.pl
Hepatocellular carcinoma (HCC) is a particularly vascularized solid tumor where the
Raf/MEK/ERK pathway is activated; suggesting that inhibition of this pathway may have …
[PDF] academia.edu

[PDF][PDF] AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC)

H Huynh, HNK Van Chanh Ngo, D Poon… - Journal of …, 2010 - academia.edu
Background & Aims: Hepatocellular carcinoma (HCC) is a particularly vascularized solid
tumor where the Raf/MEK/ERK pathway is activated; suggesting that inhibition of this …